Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers
Concentrations of proGRP in pneumonia and COPD patients were higher than in patients in the ADC and SQCC early stages and could exceed the SCLC cut-off.
Authors
- Miroslav Samaržija (ORCID: https://orcid.org/0000-0001-5303-9353)
- Lada Rumora (ORCID: https://orcid.org/0000-0002-5302-3770)
- Željko Debeljak (ORCID: https://orcid.org/0000-0002-1789-5387)
- Maja Lukić
- Andrea Vukić Dugac (ORCID: https://orcid.org/0000-0002-1522-3325)
- Marko Jakopović (ORCID: https://orcid.org/0000-0002-4815-7512)
- Gramos Begolli (ORCID: https://orcid.org/0009-0004-2412-5585)
- Jelena Knežević (ORCID: https://orcid.org/0000-0002-3152-3563)
- Ilijan Tomaš (ORCID: https://orcid.org/0000-0002-0893-7602)
- Lorna Čorak
Institutions
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
- University Clinical Center of Kosovo (XK)
- Ruđer Bošković Institute (HR)
- Klinički bolnički centar Osijek (HR)
- University of Osijek (HR)
Publication Details
- Journal
- Biochemia Medica
- Published
- 2024-12-16
- DOI
- https://doi.org/10.11613/bm.2025.010702
- Citations
- 3
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85